0001562180-18-004187.txt : 20181005 0001562180-18-004187.hdr.sgml : 20181005 20181005180240 ACCESSION NUMBER: 0001562180-18-004187 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181003 FILED AS OF DATE: 20181005 DATE AS OF CHANGE: 20181005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURDOCK TERRY L CENTRAL INDEX KEY: 0001274071 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 181111498 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 79 T.W. ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: P. O. BOX # 110341 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-10-03 false 0001560241 G1 Therapeutics, Inc. GTHX 0001274071 MURDOCK TERRY L 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 false true false false SVP of Development Operations Common Stock 2018-10-03 4 M false 3519.00 13.51 A 3519.00 D Common Stock 2018-10-03 4 S false 3519.00 49.18 D 0.00 D Stock Options (Right to Buy) 13.51 2018-10-03 4 M false 3519.00 0.00 D 2027-08-01 Common Stock 3519.00 89443.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The shares underlying this option vested as to 25% of the shares on August 1, 2018, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date. /s/ James Stillman Hanson, attorney-in-fact 2018-10-05